Vivimed Labs Ltd
Vivimed Labs Ltd Company History
Vivimed Labs is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
2009
Vivimed Labs Ltd has informed BSE that Mr. Y Krishna has been appointed as an Additional Director on the Board of the Company with effect from June 30, 2009 in the Board Meeting of the Company held on June 30, 2009.
2009
2010
Vivimed Labs Ltd has appointed Mr. Nixon Patel as an Additional Director of the Company with effect from June 28, 2010.
Mr. Nixon Patel has been appointed as an Independent Director on the Board.
2010
2011
Vivimed Labs Incorporation of Foreign Subsidiaries namely, Vivimed Labs Mauritius Ltd., Mauritius, Vivimed Labs UK Ltd., UK and Vivimed Labs Spain, SL, Spain.
Vivimed Labs has accquired majority Stake in Octtantis Nobel Labs Private Ltd.
Vivimed Labs Acquired equity stake in Klar Sehen Pvt. Ltd.
Vivimed Labs Acquired Uquifa Spain and Uquifa Mexico
2011
2012
Vivimed launch Nisarg Soapnut at in-cosmetics, Barcelona.
Mr. K. Yugandhar has been appointed as Company Secretary of the company
2012
2013
Vivimed acquires a US FDA approved formulation manufacturing facility.
Vivimed are Exhibiting at HPCi - Mumbai.
2013
2014
Vivimed receives the PIC/S GMP approval for one of its pharmaceuticals manufacturing facilities in Hyderabad.
Vivimed Labs - Grant of Options under Vivimed Labs ESOS 2010.
2014
2016
VivimedÂs FDF facility in Alathur completed successful USFDA inspection
Vivimed launch Jarocol® Sapphire Blue
2016
